35
FibroBiologics closes $1.2M raise under Regulation D exemption 6(b)
Company raise · Closed · Offering $1.2M · Sold $1.2M · HOUSTON, TX · filed 2026-10-13
40
FibroBiologics, Inc. raises $1.7M under Reg D
Company raise · Closed · HOUSTON, TX · Form D filed 2025-12-16
Placement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Robert Hoffman | Director |
| Matthew Link | Director |
| Stacy Coen | Director |
| Jason D. Davis | Chief Financial Officer |
| Pete O'Heeron | Chairman, Founder and Chief Executive Officer |
| Richard C. Cilento | Director |
| Victoria Niklas | Director |
Signed by Ruben A. Garcia, General Counsel.
Placement agents / sales compensation: H.C. Wainwright & Co., LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
35
FibroBiologics, Inc. raises $500K under Reg D
Company raise · Closed · Offering $500K · Sold $500K · HOUSTON, TX · filed 2026-09-16
45
FibroBiologics, Inc. raises $3M under Reg D
Company raise · Closed · Offering $3M · Sold $3M · HOUSTON, TX · filed 2026-06-29
Placement agent engaged
45
FibroBiologics, Inc. raises $1.5M under Reg D
Company raise · Closed · Offering $1.5M · Sold $1.5M · HOUSTON, TX · filed 2025-12-03
Placement agent engaged
45
FibroBiologics, Inc. raises $4M under Reg D
Company raise · Closed · Offering $4M · Sold $4M · HOUSTON, TX · filed 2025-12-03